Dr. Walter Koroshetz
NIH's Role in Therapy Development for Huntington's Disease
Dr. Koroshetz received his B.S. in Biology from Georgetown University, and his M.D. from the University of Chicago. He trained in Internal Medicine at the U of Chicago and the Massachusetts General Hospital (MGH) after which he trained in Neurology, did post-doctoral studies in cellular neurophysiology at MGH and the Harvard neurobiology department. He worked on excitotoxicity in striatum and with Bruce Jenkins discovered elevated lactate by MR spectroscopy in patients with Huntington's disease which was decreased by treatment with Coenzyme Q10. He joined the neurology staff, first in the Huntington's Disease unit and then in the stroke and neurointensive care service. Dr. Koroshetz served as vice chair of the neurology service and director of stroke and neurointensive care services at MGH. He was also a professor of neurology at Harvard Medical School and has led neurology resident training at MGH since 1990. Dr. Koroshetz was named Deputy Director of NINDS in January of 2007, where he works with the NINDS Director in program planning and budgeting, and oversees Institute scientific and administrative functions.